ANKRD32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.569900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.440800E-01
Normal-vs-Stage2
5.461700E-02
Normal-vs-Stage3
1.264450E-01
Normal-vs-Stage4
1.029590E-01
Stage1-vs-Stage2
6.374200E-01
Stage1-vs-Stage3
2.365200E-01
Stage1-vs-Stage4
1.402960E-01
Stage2-vs-Stage3
4.534000E-01
Stage2-vs-Stage4
2.409000E-01
Stage3-vs-Stage4
6.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.756000E-02
Normal-vs-AfricanAmerican
1.058200E-01
Normal-vs-Asian
2.253000E-01
Caucasian-vs-AfricanAmerican
6.820800E-01
Caucasian-vs-Asian
1.140000E-01
AfricanAmerican-vs-Asian
3.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.930100E-02
Normal-vs-Female
7.024500E-02
Male-vs-Female
8.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.389000E-01
Normal-vs-Age(41-60Yrs)
2.409600E-01
Normal-vs-Age(61-80Yrs)
1.480430E-02
Normal-vs-Age(81-100Yrs)
3.042200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.452800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.642600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.753600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.242500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.285700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.583800E-02
Normal-vs-Daily Drinker
6.004000E-02
Normal-vs-Weekly Drinker
2.573400E-01
Normal-vs-Occasional Drinker
1.065390E-01
Normal-vs-Social Drinker
1.401630E-01
Non Drinker-vs-Daily Drinker
8.912800E-01
Non Drinker-vs-Weekly Drinker
9.695200E-01
Non Drinker-vs-Occasional Drinker
8.992800E-01
Non Drinker-vs-Social Drinker
5.114600E-01
Daily Drinker-vs-Weekly Drinker
9.132600E-01
Daily Drinker-vs-Occasional Drinker
9.953400E-01
Daily Drinker-vs-Social Drinker
6.083800E-01
Weekly Drinker-vs-Occasional Drinker
9.093800E-01
Weekly Drinker-vs-Social Drinker
6.800800E-01
Occasional Drinker-vs-Social Drinker
6.588800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.207600E-01
Normal-vs-Grade 2
7.331200E-01
Normal-vs-Grade 3
7.451200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.254600E-01
Grade 1-vs-Grade 3
4.166800E-01
Grade 1-vs-Grade 4
7.207600E-01
Grade 2-vs-Grade 3
5.902800E-01
Grade 2-vs-Grade 4
7.331200E-01
Grade 3-vs-Grade 4
7.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.027500E-02
Normal-vs-NonDiabetic
5.037800E-02
Diabetic-vs-NonDiabetic
5.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.032800E-01
Normal-vs-NoPancreatitis
5.164400E-02
Pancreatitis-vs-NoPancreatitis
7.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.509700E-02
Normal-vs-N1
5.887900E-02
N0-vs-N1
8.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.850050E-01
Normal-vs-TP53-NonMutant
2.064200E-01
TP53-Mutant-vs-TP53-NonMutant
5.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
